The Role of Cost-Effectiveness Analysis in Health and Medicine

JAMA The Journal of the American Medical Association (Impact Factor: 35.29). 01/1997; 276(14):1172-1177. DOI: 10.1001/jama.1996.03540140060028


—To develop consensus-based recommendations guiding the conduct of cost-effectiveness analysis (CEA) to improve the comparability and quality of studies. The recommendations apply to analyses intended to inform the allocation of health care resources across a broad range of conditions and interventions. This article, first in a 3-part series, discusses how this goal affects the conduct and use of analyses. The remaining articles will outline methodological and reporting recommendations, respectively.

1 Follower
13 Reads
  • Source
    • "Additionally, economic analyses has been shown to inform clinical practice decisions in major institutions like hospitals, in determining policies in the health care system (Backhouse et al. 1992; Elixhauser et al. 1993; Russell et al. 1996). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract In an era of expanding health sectors and rising costs, doctors are expected to have a working knowledge of health economics to better use resources and improve outcomes and quality of health care. This article recognizes the dearth of knowledge and application of economic analyses in medical education and clinical practice in Saudi Arabia. In particular, it highlights the desirability of knowledge of health economics in ensuring certain competencies in medical education and the rationale for inviting doctors to apply knowledge of economics in Saudi Arabia. In addition, the article discusses challenges that hinder integrating health economics into clinical practice. Furthermore, the article typifies some of the important economic phenomena that physicians need to discern. Besides, the article provides implications for incorporating economic analysis into medical education and clinical practice in Saudi Arabia. Finally, the article concludes by demonstrating how health economics can enhance doctors' knowledge and recommends the country to move towards integrating health economics into medical education and clinical practice for best practice.
    Medical Teacher 02/2015; 37(S1):1-5. DOI:10.3109/0142159X.2015.1006611 · 1.68 Impact Factor
  • Source
    • "With medical cost dramatically increasing and the restriction of limited resources, evaluation of the cost and cost-effectiveness of therapies is a very important aspect in the decisionmaking (Russelletal., 1996). "
    01/2015; 3(1). DOI:10.15640/ijhs.v3n1a11
  • Source
    • "Based upon this previous work, it can be estimated that youth who engage in nonmedical prescription opioid use cost society approximately $8,966 per year. When discounted across the six years of program follow-up within the PROSPER trial, at a standard rate of 3%, this figure rounds to $7,500 (Russell et al., 1996). This estimate serves as the basis for a Willingness-to-Pay (WTP) threshold, where allocating less than $7,500 (i.e., the estimated societal cost of an adolescent or young adult nonmedical opioid user) to preventing a single case of nonmedical use is an economically efficient decision. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose Prescription drug abuse has reached epidemic proportions. Nonmedical prescription opioid use carries increasingly high costs. Despite the need to cultivate efforts that are both effective and fiscally responsible, the cost-effectiveness of universal evidence-based-preventive-interventions (EBPIs) is rarely evaluated. This study explores the performance of these programs to reduce nonmedical prescription opioid use. Methods Sixth graders from twenty-eight rural public school districts in Iowa and Pennsylvania were blocked by size and geographic location and then randomly assigned to experimental or control conditions (2002–2010). Within the intervention communities, prevention teams selected a universal family and school program from a menu of EBPIs. All families were offered a family-based program in the 6th grade and received one of three school-based programs in 7th-grade. The effectiveness and cost-effectiveness of each school program by itself and with an additional family-based program was assessed using propensity and marginal structural models. Results This work demonstrates that universal school-based EBPIs can efficiently reduce nonmedical prescription opioid use. Further, findings illustrate that family-based programs may be used to enhance the cost-effectiveness of school-based programs. Conclusions Universal EBPIs can effectively and efficiently reduce nonmedical prescription opioid use should be further considered when developing comprehensive responses to this growing national crisis.
    Preventive Medicine 05/2014; 62. DOI:10.1016/j.ypmed.2014.01.029 · 3.09 Impact Factor
Show more